Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: Modulation by α2-adrenoceptors

British Journal of Pharmacology

Volumn 127, Issue 8, 1999, Pages 1860-1866

  Wortley, K E ^a   Hughes, Z A ^a   Heal, D J ^b   Stanford, S C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ABBOTT LABORATORIES   (United States)

Author keywords

2 adrenoceptors; d amphetamine; Frontal cortex; in vivo microdialysis; Noradrenaline; Sibutramine

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; NORADRENALIN; SIBUTRAMINE;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; APPETITE DEPRESSANTS; CEREBRAL CORTEX; CYCLOBUTANES; DEXTROAMPHETAMINE; IDAZOXAN; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0032791234     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702720     Document Type: Article

References (38)

1. 3H]5-HT uptake: Effect of administration of various antidepressant treatments. Neuropharmacalogy, 32, 737-743.
2. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology, 35, 63-70.
3. Curet, O., DE Montigny, C. & Blier, P. (1992). Effects of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain, Eur. J. Pharmacol., 221, 59-70.
4. 2-adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline (as measured by in vivo dialysis) in the rat. J. Pharmacol. Exp. Ther., 241, 642-649.
5. Florin, S.M., Kuczenski, R. & Segal, D.S. (1994). Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain. Res., 654, 53-62.
6. 2-Adrenergic receptor blockade markedly potentiates duloxetine-and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely-moving rats. J. Neurochem., 69, 2616-2619.
7. Graham, A.W. & Aghajanian, G.K. (1971). Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus coeruleus. Nature, 234, 100-102.
8. Gundlah, C., Martin, K.F., Heal, D.J. & Auerbach, S.B. (1997). In vivo criteria to differentiate monoamine uptake inhibitors from releasing drugs: Sibutramine is a reuptake inhibitor. J. Pharmacol. Exp. Ther., 283, 581-591.
9. Halford, J.C.G., Heal, D.J. & Blundell, J.E. (1995). Effects in the rat of sibutramine on food intake and the behavioural satiety sequence. Br. J. Pharmacol., 114, 387P.
10. Heal, D.J. & Cheetham, S.C. (1997). The pharmacology of sibutramine, the first serotonin and noradrenaline reuptake inhibitor to be developed for the treatment of obesity. La lettre du pharmacologie, 11, (suppl 10), 3-8.
11. Heal, D.J., Aspley, S., Prow, M.R., Jackson, H.C., Martin, K.F. & Cheetham, S.C. (1998a). Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int. J. Obesity, 22, (Suppl 1), S18-S28.
12. Heal, D.J., Cheetham, S.C., Prow, M.R., Martin, K.F. & Buckett, W.R. (1998b). A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents. Br. J. Pharmacol., 125, 301-308.
13. Holdefer, R.N. & Jensen, R.A. (1987). The effects of peripheral D-amphetamine, 4-OH amphetamine, and epinephrine on maintained discharge in the locus coeruleus with reference to the modulation of learning and memory by these substances. Brain Res., 417, 108-117.
14. Jackson, H.C., Bearham, M.C., Hutchins, L.J., Mazurkiewicz, S.E., Needham, A.M. & Heal, D.J. (1997a). Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br. J. Pharmacol., 121, 1613-1618.
15. Jackson, N.C., Needham, A.M., Hutchins, L.J., Mazurkiewicz, S.E, & Heal, D.J. (1997b). Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br. J. Pharmacol., 121, 1758-1762.
16. 2-adrenoceptor-mediated pressor responses by halothane and isoflurane anaesthesia. Anaesthesiology, 71, 224-234.
17. Kuczenski, R. & Segal, D.S. (1992). Regional norepinephrine response to amphetamine using dialysis: Comparison with caudate dopamine. Synapse, 11, 164-169.
18. Langer, S.Z. (1977). Sixth Gaddum memorial lecture, National Institute for Medical Research, Mill Hill, Presynaptic receptors and their role in the regulation of transmitter release. Br. J. Pharmacol., 60, 481-497.
19. Langin, D., Paris, H. & Lafontan, M. (1990). Binding of [3H]idazoxan and of its methoxy derivative [3H]RX821002 in human fat cells: [3H]idazoxan but not [3H]RX821002 labels additional non-alpha2-adrenergic binding sites, Mol. Pharmacol., 37, 876-885.
20. 2-adrenoceptor mediated vasoconstriction in vivo and in vitro. Anaesthesiology, 66, 781-791.
21. L'Heureux, R.L., Dennis, T., Curet, O. & Scatton, B. (1986). Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: Effects of drugs affecting noradrenergic transmission. J. Neurochem., 46, 1794-1801.
22. Luscombe, G.P., Hopcroft, R.H., Thomas, P.C. & Buckett, W.R. (1989). The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology, 28, 129-134.
23. Mason, K., Heal, D.J. & Stanford, S.C. (1997). The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty. Pharm. Biochem Behav., 60, 321-327.
24. Meana, J.J., Herrera-Marscihtz, M., Goiny, M. & Silveira, R. (1997). Modulation of catecholamine release by alpha2-adrenoceptors and I1-imidazoline receptors in rat brain. Brain. Res., 744, 216-226.
25. Nutt, D.J., Lalies, M.D., Lione, L.A. & Hudson, A.L. (1997). Noradrenergic mechanisms in the prefrontal cortex. J. Psychopharmacol., 11, 163-168.
26. Paton, D.M. (1975). Structure-activity relations for the acceleration of efflux of noradrenaline from adrenergic nerves in rabbit atria by sympathomimetic amines. Can. J. Physiol. Pharmacol., 53, 822-829.
27. Paxinos, G. & Watson, C. (1986). The rat brain in stereotaxic coordinates. Academic Press, Australia.
28. Rudnick, G. & Wall, S.C. (1992). p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry, 31, 6710-6718.
29. Ryan, L.J., Tepper, J.M., Young, S.J. & Groves, P.M. (1985). Amphetamine's effects on terminal excitability of noradrenergic locus coeruleus neurones are impulse-dependent at low but not high doses. Brain Res., 341, 155-163.
30. Samanin, R. & Garattini, S. (1993). Neurochemical mechanism of action of anorectic drugs, Pharmacol. Toxicol., 73, 63-68.
31. Sandberg, M., Butcher, S.P. & Hagberg, H. (1986), Extra-cellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J. Neurochem., 47, 178-184.
32. Sanghvi, I.S., Singer, G., Friedman, E. & Gershon, S. (1975). Anorexigenic effects of d-amphetamine and 1-DOPA in the rat. Pharmacol. Biochem. Behav., 3, 81-86.
33. Shimokawa, A., Jin, Q.H., Ishizuka, Y., Kunitaka, T., Takasaki, M. & Kannan, H. (1998). Effects of anesthetics on norepinephrine release in the hypothalamus paraventricular nucleus region of awake rats. Neurosci. Lett., 244, 21-24.
34. Stock, M.J. (1997). Sibutramine: a review of the pharmacology of a novel antiobesity agent. Int. J. Obes., 21 (Suppl. 1), S25-S29.
35. Svensson, T.H., Bunney, B.S. & Aghajanian, G.K. (1975). Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain. Res., 92, 291-306.
36. Sulzer, D. & Rayport, S. (1990). Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron, 5, 797-808.
37. Thomas, D.N. & Holman, R.B. (1991). A microdialysis study of the regulation of endogenous noradrenaline release in the rat hippocampus. J. Neurochem., 56, 1741-1746.
38. Wikberg, J.E.S., Hede, A.R. & Post, C. (1987). Effects of halothane and other chlorinated hydrocarbons on alpha2-adrenoceptors in the mouse cortex. Pharmacol. Toxicol., 61, 271-277.